Results 141 to 150 of about 65,496 (283)
Dipeptidyl Peptidase 4 Inhibitors: Therapeutic Options
Dipeptidyl peptidase 4 inhibitors are a new innovative class of glucose-lowering drugs. The drugs belong to the group of incretin mimetics, prolonging the action of their own incretins. Since 2007, the list of proposed dipeptidyl peptidase 4 inhibitors has expanded significantly and significant experience in their use has accumulated.
S.V. Podachina, I.V. Soloviova
openaire +1 more source
Transitioning from FSL to FSL2 with rtCGM function improved sensor usage and glycemic control, particularly in patients with Type 1 diabetes. The duration required for improvement in continuous glucose monitoring‐related parameters varied by diabetes type, with early improvements observed in Type 1 diabetes and gradual improvements in Type 2 diabetes ...
Keiji Sugai +3 more
wiley +1 more source
Bifidobacterium bifidum G9‐1 improved stool form, defecation frequency, and Quality of Life in patients with type 2 diabetes mellitus and chronic kidney disease complicated by constipation. ABSTRACT Introduction Although constipation is a major complication of type 2 diabetes mellitus and chronic kidney disease, evidence for its treatment in these ...
Fuki Ikeda +10 more
wiley +1 more source
Endogenous GIP signaling is indispensable for DPP‐4 inhibitor‐mediated metabolic control in mice
This study reveals that the metabolic benefits of DPP‐4 inhibitors, including improved glucose tolerance and reduced body weight, are completely abolished in GIP receptor‐deficient mice. These findings establish that endogenous GIP signaling, rather than GLP‐1, is the indispensable key player for the efficacy of this drug class.
Saki Kubota‐Okamoto +17 more
wiley +1 more source
Serum dipeptidyl peptidase-4 in chronic liver disease patients with osteoporosis
Background and aim Fibrosis and cirrhosis are the results of the progressive degradation and regeneration of the liver parenchyma in chronic liver disease (CLD).
Nashwa Farouk Mohamed Elmetwaly +4 more
doaj +1 more source
Analgesic and anti-inflammatory effectiveness of sitagliptin and vildagliptin in mice [PDF]
Cayasso, Mayella +6 more
core +1 more source
Heart failure and dipeptidyl peptidase‐4 inhibitors [PDF]
Henry, Krum +3 more
openaire +2 more sources
Engineering of marker‐free lettuce chloroplast genome to express CTB‐Exenatide and CTB‐Lixisenatide for oral delivery. Upper panel: Chemically synthesised exenatide or lixisenatide require expensive production, purification, refrigeration and invasive delivery methods.
Rahul Singh, Henry Daniell
wiley +1 more source
Abstract Background Understanding periodontal diseases through a biological lens has been a central aim in periodontal research. Visionary pioneers in the field established the foundations of our knowledge, providing invaluable insights into disease mechanisms and progression.
Nagihan Bostanci +2 more
wiley +1 more source

